{
  "content": "53.\nSingh B.N., Singh S.N., Reda D.J., et al. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005;352:1861-1872.\nCrossref\nPubMed\nGoogle Scholar\n\na [...] compared with no rhythm-control therapy.\nb [...] AADs in the early 21st century.\n\n54.\nRoy D., Talajic M., Dorian P., et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000;342:913-920.\nCrossref\nPubMed\nGoogle Scholar\n\na [...] compared with no rhythm-control therapy.\nb [...] control and 10% to 61% for rate control.\nc [...] AADs in the early 21st century.",
  "source": "https://www.jacc.org/doi/10.1016/j.jacc.2022.03.337",
  "chunk_id": "fdbdbfbd-73d9-4e7f-af54-e74047e1ee59",
  "similarity_score": 0.39473140239715576,
  "query": "amiodarone versus beta-blockers atrial fibrillation randomized controlled trial effectiveness rhythm control rate control",
  "rank": 36,
  "title": "The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review",
  "authors": "A. John Camm, Gerald V. Naccarelli, Suneet Mittal, Harry J.G.M. Crijns, Stefan H. Hohnloser, Chang-Sheng Ma, Andrea Natale, Mintu P. Turakhia, Paulus Kirchhof",
  "year": "2022",
  "journal": "JACC",
  "reference": "Camm, A. J., Naccarelli, G. V., Mittal, S., Crijns, H. J. G. M., Hohnloser, S. H., Ma, C.-S., Natale, A., Turakhia, M. P., & Kirchhof, P. (2022). The increasing role of rhythm control in patients with atrial fibrillation: JACC state-of-the-art review. JACC, 79(19). https://doi.org/10.1016/j.jacc.2022.03.345",
  "doi": "10.1016/j.jacc.2022.03.345",
  "chunk_index": 238,
  "total_chunks": 288,
  "retrieved_at": "2025-07-24T21:57:43.521882"
}